proline has been researched along with Central Nervous System Neoplasm in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aebi, JD; Berger, Y; Blum-Kaelin, D; Dehmlow, H; Juillerat-Jeanneret, L; Kitas, EA; Löffler, BM | 1 |
Catapano, D; D'Agruma, L; D'Angelo, VA; Guarnieri, V; Muscarella, LA; Zelante, L | 1 |
2 other study(ies) available for proline and Central Nervous System Neoplasm
Article | Year |
---|---|
Endothelin-converting enzyme-1 inhibition and growth of human glioblastoma cells.
Topics: Antineoplastic Agents; Aspartic Acid Endopeptidases; Carbamates; Cell Line, Tumor; Cell Proliferation; Central Nervous System Neoplasms; Drug Screening Assays, Antitumor; Endothelin-1; Endothelin-Converting Enzymes; Glioblastoma; Humans; Hydrazines; Metalloendopeptidases; Proline; Pyrimidines; Pyrrolidines; Structure-Activity Relationship; Sulfhydryl Compounds | 2005 |
Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management.
Topics: Adult; Aged; Arginine; Central Nervous System Neoplasms; DNA Mutational Analysis; Exons; Female; Hemangioblastoma; Humans; Leucine; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Biology; Mutation, Missense; Proline; Retrospective Studies; Tryptophan; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2005 |